Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 7, 2015; 21(13): 3960-3969
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3960
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3960
Figure 1 Gene expression and methylation analyses of IRAK3 and GLOXD1.
A: Gene expression levels of IRAK3, GLOXD1, and GAPDH (an internal reference gene) were analyzed by RT-PCR in normal controls, THLE-3 cells, 6 HCC cell lines, and HCC cell lines treated with 5DAC; B: Methylation status of IRAK3, GLOXD1, and COL2A (an internal reference gene) was analyzed by MS-PCR with methylated primers in normal controls, THLE-3 cells, 6 HCC cell lines, and HCC cell lines treated with 5DAC. Positive and negative are peripheral blood lymphocyte (PBL) DNA in vitro treated with or without CpG methyltransferase (M.SssI). 1/5 positive and 1/10 positive indicate 1:5 and 1:10 dilution of the positive control.
-
Citation: Kuo CC, Shih YL, Su HY, Yan MD, Hsieh CB, Liu CY, Huang WT, Yu MH, Lin YW. Methylation of
IRAK3 is a novel prognostic marker in hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3960-3969 - URL: https://www.wjgnet.com/1007-9327/full/v21/i13/3960.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i13.3960